Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- Check2 days agoChange DetectedNew help and navigation items were added to the page (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was adjusted, with the site revision updated to v3.6.0.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small backend/documentation update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a 2024 literature citation about switching from intravenous to subcutaneous infliximab in inflammatory bowel disease. Updated the page revision to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a web UI or backend build update rather than a change to the clinical study information.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.